Since its founding in 2022 by the pan-European private equity investor Apheon and Dr. Reinhard Wichels, the Munich-based startup Ortivity has developed into the leading platform for outpatient orthopedic care in Germany. With more than 100 locations in three regional clusters, the company covers the entire spectrum of orthopedic services – from diagnostics and surgery to aftercare. Its foundation is a physician-led partnership model in which ownership shares are equally divided between physicians and investors.
To implement its growth plans, Apheon brought another investor on board: Unigestion, a company specializing in mid-market private equity, is investing around 200 million euros in Ortivity and thus acquires a minority stake. Apheon remains the lead investor and continues to hold the majority stake.
Expansion of regional clusters
The fresh capital will be used to strengthen existing clusters and establish new ones in order to “gradually convert the German orthopedic market to a modern, outpatient model.” Nils Lüssem, Partner at Apheon, and Sebastian Walter, Director at Apheon, commented in this context:
“The partnership with Unigestion ensures that we have the necessary capital to continue our growth and continue investing in world-class patient care.”
Medically oriented leadership
Ortivity sees the new partnership as a validation of its physician-led model. Dr. med. Michael Thorwarth, newly appointed Co-CEO of Ortivity, summarizes:
“Together, we want to set new standards in treatment quality and patient-centered services and create measurable benefits for our patients.”
The transaction is still subject to customary regulatory approvals.
